Frost & Sullivan

Recent Events

News & Analysis

frost & sullivan and therapy - All News and Analysis

• Targeted Therapies to Lead New Wave of Breast Cancer Treatments

  - 2008-06-30

  PALO ALTO, Calif. -- Rising public awareness about breast cancer and the treatments available has greatly improved revenues in the overall breast cancer therapeutics market. To thrive in this highly competitive market, drug developers must offer drugs that improve survival rates and the quality of life. New analysis from...

  Tags: Frost & Sullivan, therapy

• Cadaveric Bone Implants Emerge as Cheaper Alternatives to Metallic Prosthetics in Bone Regeneration Therapy

  - 2008-06-23

  PALO ALTO, Calif. -- As cadaveric bone implants have the same structural integrity as a normal human bone, they will integrate easily with the body and support the bodily functions well. Since it mimics the normal human bone in its chemical composition, these cadaveric implants, once sterilized and placed inside...

  Tags: Frost & Sullivan, integration, mobility, patient, prosthetics, therapy, wheelchair

• New Product Launches Set to Unleash Multiple Growth Avenues in U.S. Monoclonal Antibodies Market

  - 2008-06-09

  PALO ALTO, Calif. -- The U.S. therapeutic monoclonal antibodies market is poised for a quantum leap with the launch of a multitude of new products and vigorous expansion of therapeutic indications of existing products. A combination of these factors, along with high demand and lack of generic competition, expects to...

  Tags: E-mail, Frost & Sullivan, Government, patient, therapy

• Age and Ethnicity of Patients Influence Development of Cardiovascular Drug Therapies

  - 2008-05-27

  PALO ALTO, Calif. -- The rising prevalence of cardiovascular conditions such as stroke, heart failure and coronary artery disease CAD hastens the development of suitable cardiovascular drug therapies among the elderly. The risks involved in surgeries on elderly patients and the existence of a patient category, in which long-term dietary...

  Tags: Frost & Sullivan, patient, therapy

• Tremendous Potential for Fibromyalgia Pharmaceuticals in Europe

  - 2008-05-19

  LONDON -- With no available therapy for the treatment of fibromyalgia syndrome FS, pharmaceutical companies have shown great interested in coming up with possible recommendations and therapies for treatment. Central nervous system CNS niche disorders have always been a major challenge and FS is no different. Some of the key...

  Tags: Frost & Sullivan, therapy

• Constant Demand for Better Therapies Keeps Medical Device Manufacturers on their Toes

  - 2008-03-18

  PALO ALTO, Calif. -- Greater awareness of the availability of improved therapies is prompting patients to demand treatments that enable them to lead productive lives post surgery. This trend, coupled with surgeons' willingness to adopt innovative technologies, provided they offer superior clinical outcomes, has considerably benefited the U.S. medical devices...

  Tags: Frost & Sullivan, HEALTHCARE, surgery, therapy

• Accentia Biopharmaceutical's Revimmune Receives the Frost & Sullivan Multiple Sclerosis Product Innovation of the Year Award

  - 2008-03-13

  TAMPA, Fla. -- Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) today announced that Revimmune[TM], its potential blockbuster therapeutic candidate designed to treat up to 80 autoimmune diseases, has been awarded the Frost & Sullivan 2007 North American Multiple Sclerosis Product Innovation of the Year Award. If approved, Revimmune would be the first product...

  Tags: Biovest International Inc., Company, Frost & Sullivan, HEALTHCARE, patient, therapy

• International Funding for African Healthcare Targets Key Problem Areas

  - 2008-03-11

  CAPE TOWN, South Africa -- Sizeable international funding is targeting the serious health challenges across sub-Saharan Africa. However, even as donors pledge significant amounts to AIDS, malaria and tuberculosis TB projects, information regarding the sources, values and destinations of the funding remain limited. New analysis from global growth consulting...

  Tags: Benefits, Frost & Sullivan, HEALTHCARE, malaria, SOFTWARE, therapy

• Robust New Technology Platforms Aid the Search for Cancer Vaccines

  - 2008-02-22

  PALO ALTO, Calif. -- Although the cancer vaccine industry has remained historically undervalued due to its failures, optimism surrounds the industry as proponents of this technology have persistently pursued investigations to demonstrate the clinical efficacy of cancer vaccines. Cancer vaccines hold the potential to treat patients at an earlier stage...

  Tags: Frost & Sullivan, Strategy, therapy, vaccine

• The Race is On: Pharmaceutical Companies Compete to Develop Less Toxic More Efficacious Therapies to Combat Breast Cancer

  - 2008-02-19

  PALO ALTO, Calif. -- The Pharmaceutical / Biotechnology Group at Frost & Sullivan is pleased to announce its 2008 Quarterly Analyst Briefing Presentation on the targeted therapies segment of U.S. breast cancer therapeutics market to be held on Tuesday, February 26, 2008 at 12:00 p.m. CST / 1:00 p.m. EST....

  Tags: Frost & Sullivan, therapy